Short description
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Description
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarily affecting girls that enable clients with providing therapy for it.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Leiden, Zuid-Holland, The Netherlands, Europe
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noaccess, Noway Youcantaccess, Noaccessforu, Noaccess, No Way, Noaccessforu, Nopepepe, Cannot Access, Blurry Noaccess
Sign in for full access
Founders
Gail Mandel, Josh Mandel-Brehm, Judith van Deutekom, Luc Dochez